Eloxx Pharmaceuticals ELOX Stock
Eloxx Pharmaceuticals Price Chart
Eloxx Pharmaceuticals ELOX Financial and Trading Overview
| Eloxx Pharmaceuticals stock price | 1.02 USD |
| Previous Close | 6.98 USD |
| Open | 7.17 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1100 |
| Day's Range | 6.24 - 7.58 USD |
| 52 Week Range | 1.7 - 19.2 USD |
| Volume | 127.73K USD |
| Avg. Volume | 493.97K USD |
| Market Cap | 13.78M USD |
| Beta (5Y Monthly) | 2.756338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.88 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 50 USD |
ELOX Valuation Measures
| Enterprise Value | 28.99M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.72768885 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.004 |
Trading Information
Eloxx Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 2.756338 |
| 52-Week Change | -41.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.2 USD |
| 52 Week Low | 1.7 USD |
| 50-Day Moving Average | 6.96 USD |
| 200-Day Moving Average | 5.64 USD |
ELOX Share Statistics
| Avg. Volume (3 month) | 493.97K USD |
| Avg. Daily Volume (10-Days) | 70.46K USD |
| Shares Outstanding | 2.17M |
| Float | 1.66M |
| Short Ratio | 0.1 |
| % Held by Insiders | 0.68% |
| % Held by Institutions | 43.96% |
| Shares Short | 68.17K |
| Short % of Float | 3.81% |
| Short % of Shares Outstanding | 3.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -71.20% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -28878000 USD |
| Net Income Avi to Common (ttm) | -30675000 USD |
| Diluted EPS (ttm) | -17.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.9M USD |
| Total Cash Per Share (mrq) | 2.26 USD |
| Total Debt (mrq) | 18.77M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.329 |
| Book Value Per Share (mrq) | -7.521 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29168000 USD |
| Levered Free Cash Flow (ttm) | -17702876 USD |
Profile of Eloxx Pharmaceuticals
| Country | United States |
| State | MA |
| City | Watertown |
| Address | 480 Arsenal Way |
| ZIP | 02472 |
| Phone | 781 577 5300 |
| Website | https://www.eloxxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
Q&A For Eloxx Pharmaceuticals Stock
What is a current ELOX stock price?
Eloxx Pharmaceuticals ELOX stock price today per share is 1.02 USD.
How to purchase Eloxx Pharmaceuticals stock?
You can buy ELOX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eloxx Pharmaceuticals?
The stock symbol or ticker of Eloxx Pharmaceuticals is ELOX.
Which industry does the Eloxx Pharmaceuticals company belong to?
The Eloxx Pharmaceuticals industry is Biotechnology.
How many shares does Eloxx Pharmaceuticals have in circulation?
The max supply of Eloxx Pharmaceuticals shares is 3.14M.
What is Eloxx Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eloxx Pharmaceuticals PE Ratio is now.
What was Eloxx Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eloxx Pharmaceuticals EPS is -8.88 USD over the trailing 12 months.
Which sector does the Eloxx Pharmaceuticals company belong to?
The Eloxx Pharmaceuticals sector is Healthcare.
Eloxx Pharmaceuticals ELOX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}